Offer - Urjas Oil for just ₹ 1
Duracard 4 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of High BP. Duracard 4 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Duracard 4 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Duracard 4 Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Duracard 4 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Duracard 4 Tablet's effect is Severe during pregnancy and Severe for lactating mothers. It is important to know if Duracard 4 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Duracard 4 Tablet related warnings section.
Duracard 4 Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Liver Disease, Neutropenia as it can result in adverse effects. Other contraindications of Duracard 4 Tablet have been discussed in the sections ahead.
Drug reaction of Duracard 4 Tablet with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Duracard 4 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Duracard 4 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Male) |
|
| Adult |
|
| Geriatric |
|
Is the use of Duracard 4 Tablet safe for pregnant women?
Duracard has many dangerous side effects in pregnant women. If you are pregnant, do not consume Duracard without medical advice.
Is the use of Duracard 4 Tablet safe during breastfeeding?
Duracard may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Duracard 4 Tablet on the Kidneys?
There are no side effects of Duracard on the kidneys.
What is the effect of Duracard 4 Tablet on the Liver?
Duracard is rarely harmful for the liver.
What is the effect of Duracard 4 Tablet on the Heart?
Duracard may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Duracard 4 Tablet unless your doctor advises you to do so -
Is this Duracard 4 Tablet habit forming or addictive?
Duracard 4 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Duracard 4 Tablet. So it is best to avoid driving.
Is it safe?
Duracard 4 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Duracard 4 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Duracard 4 Tablet
Taking Duracard 4 Tablet with food does not harm your health.
Interaction between Alcohol and Duracard 4 Tablet
Taking Duracard 4 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cardura® (doxazosin mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 461-462
